000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 2 - Net Loss Per Common Share link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 3 - Accrued Liabilities link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 4 - Business Combination link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 5 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 6 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 7 - Debt link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 8 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 9 - Thyroid Cytopathology Partners link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 10 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 2 - Net Loss Per Common Share (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 3 - Accrued Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 4 - Business Combination (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 6 - Commitments and Contingencies (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 7 - Debt (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 8 - Stockholders' Equity (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies - Schedule of Third-party Payers as a Percentage of Total (Details) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 2 - Net Loss Per Common Share - Anti-dilutive Common Stock Equivalents Excluded from Diluted Net Loss Per Common Share (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 3 - Accrued Liabilities - Accrued Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 4 - Business Combination (Details Textual) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 4 - Business Combination - Fair Values of Assets Acquired and Liabilities Assumed (Details) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 4 - Business Combination - Estimated Useful Life of Acquisition-related Intangibles (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 5 - Fair Value Measurements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 6 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 6 - Commitments and Contingencies - Future Minimum Lease Payments (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 7 - Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 7 - Debt - Net Debt Obligation for Borrowings (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 8 - Stockholders' Equity - Reserved Shares of Common Stock for Issuance (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 9 - Thyroid Cytopathology Partners (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 10 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink